Skip to content
10-Q

Quarterly Report

NxStage Medical, Inc.

0001333170-17-000023

← back to feed
Filed
Nov 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 2, 2017 66.23M sh
Long Term Debt Q3 2017 · Sep 30, 2017 $551K
Long Term Debt Q3 2017 · Dec 31, 2016 $1.31M
Short Term Debt Q3 2017 · Sep 30, 2017 $99K
Short Term Debt Q3 2017 · Dec 31, 2016 $328K
Stockholders Equity Q3 2017 · Sep 30, 2017 $213.32M
Stockholders Equity Q3 2017 · Dec 31, 2016 $201.4M
Current Liabilities Q3 2017 · Sep 30, 2017 $46.2M
Current Liabilities Q3 2017 · Dec 31, 2016 $49.26M
Total Liabilities Q3 2017 · Sep 30, 2017 $112.16M
Total Liabilities Q3 2017 · Dec 31, 2016 $115.13M
Current Assets Q3 2017 · Sep 30, 2017 $151.93M
Current Assets Q3 2017 · Dec 31, 2016 $144.9M
Total Assets Q3 2017 · Sep 30, 2017 $325.35M
Total Assets Q3 2017 · Dec 31, 2016 $317.21M
Capex Q3 2017 · Sep 30, 2016 $6.8M
Cash And Equivalents Q3 2017 · Sep 30, 2016 $60.82M
Cash And Equivalents Q3 2017 · Dec 31, 2015 $59.07M
Sga Expense Q3 2017 · Sep 30, 2016 $7.79M
Sga Expense Q3 2017 · Sep 30, 2016 $24.33M
Rd Expense Q3 2017 · Sep 30, 2016 $8.28M
Rd Expense Q3 2017 · Sep 30, 2016 $23.39M
Net Income Q3 2017 · Sep 30, 2016 −$166K
Net Income Q3 2017 · Sep 30, 2016 −$3.17M
Operating Income Q3 2017 · Sep 30, 2016 $24K
Operating Income Q3 2017 · Sep 30, 2016 −$2.13M
Gross Profit Q3 2017 · Sep 30, 2016 $39.18M
Gross Profit Q3 2017 · Sep 30, 2016 $114.12M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $52.77M
Cost Of Revenue Q3 2017 · Sep 30, 2016 $159.24M